usa-map usa-map

Visit The Maine State Page To Take Action!

Learn more

Resources

Managing Access to Pseudoephedrine

“Managing Access to Pseudoephedrine / Potential Impacts of a Prescription-Only Policy versus Real-Time Stop Sale Technology,” an analysis by Avalere aims to identify the potential economic impacts of each approach to controlling consumer access to PSE-containing drugs on major stakeholders—the federal government, state governments, healthcare providers, commercial health insurance plans, and consumers.

An Analysis of the Economic Impact of Requiring Prescriptions for Pseudoephedrine Products

An Analysis of the Economic Impact of Requiring Prescriptions for Pseudoephedrine Products” written by Alex Brill at the Matrix Global Advisors (MGA) is an overview discussing the federal and state legaslative environment as well as the economic cost of a national prescription-only policy for PSE products.

Indiana Economic Impact Study from Ball State University

The Cost-Benefit Analysis of Pseudoephedrine Drug Laws in Indiana,” an analysis by Ball State University’s Center for Business and Economic Research (CBER), The objective of this study is to evaluate the impact of making a prescription necessary for consumers to purchase cold and allergy medicines that contain PSE, including estimating Medicaid spending, cost to households, loss in sales tax revenues to the state government, and productivity loss to the employers in Indiana using both models of historical data and simulation.